Diet and Exercise or Normal Care in Overweight or Obese Women Who Have Undergone Treatment for Stage I, Stage II, or Stage III Breast Cancer
NCT00689975 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2013-08-26
Summary
RATIONALE: Studying diet and exercise interventions in overweight and obese patients with breast cancer may help doctors learn more about how to help patients lose weight and change their body composition.
PURPOSE: This randomized clinical trial is studying diet and exercise to see how well it works compared with normal care in overweight or obese women who have undergone treatment for stage I, stage II, or stage III breast cancer.
Conditions
Interventions
- BEHAVIORAL
-
behavioral dietary intervention
- BEHAVIORAL
-
exercise intervention
- OTHER
-
counseling intervention
- OTHER
-
flow cytometry
- OTHER
-
immunoenzyme technique
- OTHER
-
laboratory biomarker analysis
- PROCEDURE
-
complementary or alternative medicine procedure
- PROCEDURE
-
standard follow-up care
Sponsors & Collaborators
-
Sheffield Hallam University
lead OTHER
Principal Investigators
-
John M. Saxton, PhD · Royal Hallamshire Hospital
Study Design
- Allocation
- RANDOMIZED
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-02-28
- Primary Completion
- 2008-10-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer
NCT00872625 ·Status: COMPLETED ·Phase: PHASE1
-
Exercise Program in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
NCT03280836 ·Status: COMPLETED ·Phase: NA
-
Chemotherapy-induced Lipid Profile Changes in Women With Early Breast Cancer
NCT06958783 ·Status: COMPLETED
-
Study of Aerobic Training for People Receiving Chemotherapy for Breast Cancer
NCT05716893 ·Status: RECRUITING ·Phase: PHASE2
-
S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
NCT00003095 ·Status: COMPLETED
-
Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer
NCT06207734 ·Status: RECRUITING ·Phase: PHASE2
-
Exercise for Ameliorating Chemotherapy Cardiotoxicity
NCT06595316 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study
NCT05019989 ·Status: COMPLETED ·Phase: NA
-
Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.
NCT03027063 ·Status: COMPLETED ·Phase: NA
-
Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival
NCT02364557 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Metabolic Parameters and Quality of Life in Women on Neo-/Adjuvant Therapy for Breast Cancer
NCT07044791 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
NCT00002772 ·Status: TERMINATED ·Phase: PHASE3
-
Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery
NCT03624478 ·Status: COMPLETED ·Phase: PHASE2
-
STOP Heart Disease in Breast Cancer Survivors Trial
NCT02674204 ·Status: TERMINATED ·Phase: PHASE2
-
Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
NCT01982591 ·Status: COMPLETED
-
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
NCT01547741 ·Status: UNKNOWN ·Phase: PHASE3
-
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
NCT03939481 ·Status: ACTIVE_NOT_RECRUITING
-
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
NCT05020860 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer
NCT00089479 ·Status: COMPLETED ·Phase: PHASE3
-
Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy
NCT06190600 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344
NCT00897026 ·Status: COMPLETED
-
A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer
NCT02999477 ·Status: COMPLETED ·Phase: PHASE1
-
High-Intensity Interval Training for Stage I-III Breast Cancer Patients
NCT02454777 ·Status: TERMINATED ·Phase: NA
-
Combination Chemotherapy in Treating Women With Resected Breast Cancer
NCT00033683 ·Status: UNKNOWN ·Phase: PHASE2
-
Trial of Partial Breast Irradiation With Various Concurrent Chemotherapy Regimens
NCT00681993 ·Status: COMPLETED ·Phase: NA